Reframing Palliative Care in PAH: Early Integration to Improve Outcomes
Hypertrophic Cardiomyopathy: Overcoming Practical Barriers to Treatment in the Era of Myosin Inhibitors
Florian Rader, MD
Targeting Macrophages in Pulmonary Arterial Hypertension
Silencers and Stabilizers in ATTR-CM: Challenging Assumptions
Counseling Patients on Disease Progression in ATTR-CM
Joban Vaishnav, MD
Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
Joseph Rossano, MD
Rebalancing Amyloid in ATTR-CM: Emerging Therapeutic Insights
Hallie Blevins, PhD
Heart Failure Hospitalization and Mortality in Cardiac Amyloidosis
Integrating CMR and Genetics to Improve ATTR-CM Diagnosis
Ryan Quigley
AI-Driven Advances in ATTR-CM Care
Frederick Ruberg, MD
Disease-Modifying Advances in ATTR-CM Management
Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
Maria Pabon, MD
Robert J. Mentz, MD, FHFSA, FACC
FAI and the Future of Cardiac Risk Stratification
Plasma Biomarkers Associated with HF Hospitalization in Atrial Fibrillation
Hidden HFpEF in Atrial Fibrillation: A Missed Diagnosis with Real Consequences
Understanding Vutrisiran’s Cardiac Effects in HELIOS-B
Steve Jackson, PharmD
Karola Jering, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.